Report Detail

Other Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size, Status and Forecast 2020-2026

  • RnM4127054
  • |
  • 12 August, 2020
  • |
  • Global
  • |
  • 129 Pages
  • |
  • QYResearch
  • |
  • Other

Point-of-Care Infectious Disease Diagnostics/Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Point-of-Care Infectious Disease Diagnostics/Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Abbott
Thermo Fisher Scientific Inc
F. Hoffmann-La Roche Ltd
Siemens Healthineers
BD & Company
Chembio Diagnostics Inc.
Trinity Biotech
Cardinal Health
Quest Diagnostics Inc.
Bio-Rad Labs Inc.
bioMérieux SA
Sight Diagnostics Ltd.
Gene POC
Trivitron Healthcare
OJ-Bio Ltd.
Ortho-Clinical Diagnostics

Market segment by Type, the product can be split into
HIV POC
Clostridium difficile POC
HBV POC
Pneumonia or Streptococcus associated infections
Respiratory syncytial virus (RSV) POC
HPV POC
Influenza/Flu POC
Other Infectious Disease POC
Market segment by Application, split into
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratories
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America


1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Point-of-Care Infectious Disease Diagnostics/Testing Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 HIV POC
    • 1.4.3 Clostridium difficile POC
    • 1.4.4 HBV POC
    • 1.4.5 Pneumonia or Streptococcus associated infections
    • 1.4.6 Respiratory syncytial virus (RSV) POC
    • 1.4.7 HPV POC
    • 1.4.8 Influenza/Flu POC
    • 1.4.9 Other Infectious Disease POC
  • 1.5 Market by Application
    • 1.5.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals
    • 1.5.3 Clinics
    • 1.5.4 Home
    • 1.5.5 Assisted Living Healthcare Facilities
    • 1.5.6 Laboratories
    • 1.5.7 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Perspective (2015-2026)
  • 2.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Growth Trends by Regions
    • 2.2.1 Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Point-of-Care Infectious Disease Diagnostics/Testing Historic Market Share by Regions (2015-2020)
    • 2.2.3 Point-of-Care Infectious Disease Diagnostics/Testing Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Point-of-Care Infectious Disease Diagnostics/Testing Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Point-of-Care Infectious Disease Diagnostics/Testing Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Point-of-Care Infectious Disease Diagnostics/Testing Players by Market Size
    • 3.1.1 Global Top Point-of-Care Infectious Disease Diagnostics/Testing Players by Revenue (2015-2020)
    • 3.1.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Concentration Ratio
    • 3.2.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Point-of-Care Infectious Disease Diagnostics/Testing Revenue in 2019
  • 3.3 Point-of-Care Infectious Disease Diagnostics/Testing Key Players Head office and Area Served
  • 3.4 Key Players Point-of-Care Infectious Disease Diagnostics/Testing Product Solution and Service
  • 3.5 Date of Enter into Point-of-Care Infectious Disease Diagnostics/Testing Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Historic Market Size by Type (2015-2020)
  • 4.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)
  • 5.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2020)
  • 6.2 Point-of-Care Infectious Disease Diagnostics/Testing Key Players in North America (2019-2020)
  • 6.3 North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
  • 6.4 North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2020)
  • 7.2 Point-of-Care Infectious Disease Diagnostics/Testing Key Players in Europe (2019-2020)
  • 7.3 Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
  • 7.4 Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)

8 China

  • 8.1 China Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2020)
  • 8.2 Point-of-Care Infectious Disease Diagnostics/Testing Key Players in China (2019-2020)
  • 8.3 China Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
  • 8.4 China Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2020)
  • 9.2 Point-of-Care Infectious Disease Diagnostics/Testing Key Players in Japan (2019-2020)
  • 9.3 Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
  • 9.4 Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2020)
  • 10.2 Point-of-Care Infectious Disease Diagnostics/Testing Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)

11 India

  • 11.1 India Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2020)
  • 11.2 Point-of-Care Infectious Disease Diagnostics/Testing Key Players in India (2019-2020)
  • 11.3 India Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
  • 11.4 India Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2020)
  • 12.2 Point-of-Care Infectious Disease Diagnostics/Testing Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
  • 12.4 Central & South America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Abbott
    • 13.1.1 Abbott Company Details
    • 13.1.2 Abbott Business Overview
    • 13.1.3 Abbott Point-of-Care Infectious Disease Diagnostics/Testing Introduction
    • 13.1.4 Abbott Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020))
    • 13.1.5 Abbott Recent Development
  • 13.2 Thermo Fisher Scientific Inc
    • 13.2.1 Thermo Fisher Scientific Inc Company Details
    • 13.2.2 Thermo Fisher Scientific Inc Business Overview
    • 13.2.3 Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics/Testing Introduction
    • 13.2.4 Thermo Fisher Scientific Inc Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
    • 13.2.5 Thermo Fisher Scientific Inc Recent Development
  • 13.3 F. Hoffmann-La Roche Ltd
    • 13.3.1 F. Hoffmann-La Roche Ltd Company Details
    • 13.3.2 F. Hoffmann-La Roche Ltd Business Overview
    • 13.3.3 F. Hoffmann-La Roche Ltd Point-of-Care Infectious Disease Diagnostics/Testing Introduction
    • 13.3.4 F. Hoffmann-La Roche Ltd Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
    • 13.3.5 F. Hoffmann-La Roche Ltd Recent Development
  • 13.4 Siemens Healthineers
    • 13.4.1 Siemens Healthineers Company Details
    • 13.4.2 Siemens Healthineers Business Overview
    • 13.4.3 Siemens Healthineers Point-of-Care Infectious Disease Diagnostics/Testing Introduction
    • 13.4.4 Siemens Healthineers Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
    • 13.4.5 Siemens Healthineers Recent Development
  • 13.5 BD & Company
    • 13.5.1 BD & Company Company Details
    • 13.5.2 BD & Company Business Overview
    • 13.5.3 BD & Company Point-of-Care Infectious Disease Diagnostics/Testing Introduction
    • 13.5.4 BD & Company Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
    • 13.5.5 BD & Company Recent Development
  • 13.6 Chembio Diagnostics Inc.
    • 13.6.1 Chembio Diagnostics Inc. Company Details
    • 13.6.2 Chembio Diagnostics Inc. Business Overview
    • 13.6.3 Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Introduction
    • 13.6.4 Chembio Diagnostics Inc. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
    • 13.6.5 Chembio Diagnostics Inc. Recent Development
  • 13.7 Trinity Biotech
    • 13.7.1 Trinity Biotech Company Details
    • 13.7.2 Trinity Biotech Business Overview
    • 13.7.3 Trinity Biotech Point-of-Care Infectious Disease Diagnostics/Testing Introduction
    • 13.7.4 Trinity Biotech Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
    • 13.7.5 Trinity Biotech Recent Development
  • 13.8 Cardinal Health
    • 13.8.1 Cardinal Health Company Details
    • 13.8.2 Cardinal Health Business Overview
    • 13.8.3 Cardinal Health Point-of-Care Infectious Disease Diagnostics/Testing Introduction
    • 13.8.4 Cardinal Health Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
    • 13.8.5 Cardinal Health Recent Development
  • 13.9 Quest Diagnostics Inc.
    • 13.9.1 Quest Diagnostics Inc. Company Details
    • 13.9.2 Quest Diagnostics Inc. Business Overview
    • 13.9.3 Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Introduction
    • 13.9.4 Quest Diagnostics Inc. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
    • 13.9.5 Quest Diagnostics Inc. Recent Development
  • 13.10 Bio-Rad Labs Inc.
    • 13.10.1 Bio-Rad Labs Inc. Company Details
    • 13.10.2 Bio-Rad Labs Inc. Business Overview
    • 13.10.3 Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics/Testing Introduction
    • 13.10.4 Bio-Rad Labs Inc. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
    • 13.10.5 Bio-Rad Labs Inc. Recent Development
  • 13.11 bioMérieux SA
    • 10.11.1 bioMérieux SA Company Details
    • 10.11.2 bioMérieux SA Business Overview
    • 10.11.3 bioMérieux SA Point-of-Care Infectious Disease Diagnostics/Testing Introduction
    • 10.11.4 bioMérieux SA Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
    • 10.11.5 bioMérieux SA Recent Development
  • 13.12 Sight Diagnostics Ltd.
    • 10.12.1 Sight Diagnostics Ltd. Company Details
    • 10.12.2 Sight Diagnostics Ltd. Business Overview
    • 10.12.3 Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Introduction
    • 10.12.4 Sight Diagnostics Ltd. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
    • 10.12.5 Sight Diagnostics Ltd. Recent Development
  • 13.13 Gene POC
    • 10.13.1 Gene POC Company Details
    • 10.13.2 Gene POC Business Overview
    • 10.13.3 Gene POC Point-of-Care Infectious Disease Diagnostics/Testing Introduction
    • 10.13.4 Gene POC Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
    • 10.13.5 Gene POC Recent Development
  • 13.14 Trivitron Healthcare
    • 10.14.1 Trivitron Healthcare Company Details
    • 10.14.2 Trivitron Healthcare Business Overview
    • 10.14.3 Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics/Testing Introduction
    • 10.14.4 Trivitron Healthcare Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
    • 10.14.5 Trivitron Healthcare Recent Development
  • 13.15 OJ-Bio Ltd.
    • 10.15.1 OJ-Bio Ltd. Company Details
    • 10.15.2 OJ-Bio Ltd. Business Overview
    • 10.15.3 OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Introduction
    • 10.15.4 OJ-Bio Ltd. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
    • 10.15.5 OJ-Bio Ltd. Recent Development
  • 13.16 Ortho-Clinical Diagnostics
    • 10.16.1 Ortho-Clinical Diagnostics Company Details
    • 10.16.2 Ortho-Clinical Diagnostics Business Overview
    • 10.16.3 Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics/Testing Introduction
    • 10.16.4 Ortho-Clinical Diagnostics Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
    • 10.16.5 Ortho-Clinical Diagnostics Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Summary:
    Get latest Market Research Reports on Point-of-Care Infectious Disease Diagnostics/Testing. Industry analysis & Market Report on Point-of-Care Infectious Disease Diagnostics/Testing is a syndicated market report, published as Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of Point-of-Care Infectious Disease Diagnostics/Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,010.80
    4,516.20
    6,021.60
    3,584.10
    5,376.15
    7,168.20
    593,073.00
    889,609.50
    1,186,146.00
    328,224.00
    492,336.00
    656,448.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report